How can we cure CMV latency?

In episode 5 we talk with Dr Mike Weekes, a clinical consultant and Wellcome Trust Senior Clinical Fellow at the University of Cambridge about his lab’s work on using a technique he pioneered called ‘quantitative temporal viromics’ (which is a kind of proteomics). The Weekes lab uses this method to understand infection by human cytomegalovirus (HCMV – also known as human herpes virus 5) with an overall aim of discovering novel antiviral targets, which are required urgently. Image from Weekes et al., Cell. 2014 Jun 5;157(6):1460-72. doi: 10.1016/j.cell.2014.04.028. Edited intro/outro music credit: 'Take me higher' by 'Jahzzar'. freemusicarchive.org/music/Jahzzar/…Me_Higher_1626 (creativecommons.org/licenses/by-sa/4.0/).